Unknown

Dataset Information

0

Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors.


ABSTRACT: Human norovirus (HuNoV) is the primary viral pathogen that causes acute gastroenteritis (AGE) in humans. The protruding (P) domain of HuNoV interacts with cell surface histo-blood group antigens (HBGAs) to initiate infection. Owing to the lack of an effective in vitro culture method and a robust animal model, our understanding of HuNoVs is limited, and as a result, there are no commercial vaccines or antivirals available at present against the virus. In an attempt to develop a preventative measure, we previously identified that bovine colostrum (bCM) contains functional factors that inhibit the binding of HuNoV P domain to its HBGA receptors. In this study, a candidate functional factor in bCM was identified as immunoglobulin M (IgM) using mass spectrometry, followed by database comparison. The natural antibody IgM was further verified to be a functional protein that inhibited HuNoV P protein binding to HBGA receptors through receptor-binding inhibition experiments using bCM, commercial IgM, and fetal bovine serum. Our findings provide a foundation for future development of natural IgM into an antiviral drug, which may help to prevent and/or treat HuNoV infection.

SUBMITTER: Han Q 

PROVIDER: S-EPMC9340781 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bovine natural antibody IgM inhibits the binding of human norovirus protruding domain to its HBGA receptors.

Han Qi Q   Xue Zhaolei Z   Tan Ming M   Wang Likai L   Chen Huiling H   Zhang Ran R  

FEBS open bio 20220616 8


Human norovirus (HuNoV) is the primary viral pathogen that causes acute gastroenteritis (AGE) in humans. The protruding (P) domain of HuNoV interacts with cell surface histo-blood group antigens (HBGAs) to initiate infection. Owing to the lack of an effective in vitro culture method and a robust animal model, our understanding of HuNoVs is limited, and as a result, there are no commercial vaccines or antivirals available at present against the virus. In an attempt to develop a preventative measu  ...[more]

Similar Datasets

| S-EPMC8308730 | biostudies-literature
| S-EPMC5056091 | biostudies-literature
| S-EPMC7331980 | biostudies-literature
| S-EPMC9924141 | biostudies-literature
| S-EPMC5952153 | biostudies-literature
| S-EPMC4810633 | biostudies-literature
| S-EPMC3503251 | biostudies-literature
| S-EPMC2876589 | biostudies-literature
| S-EPMC4493018 | biostudies-literature
| S-EPMC3302348 | biostudies-literature